Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-13-404110
Filing Date
2013-10-18
Accepted
2013-10-18 17:27:47
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d611127d10qa.htm 10-Q/A 287970
2 EX-31.1 d611127dex311.htm EX-31.1 6382
3 EX-31.2 d611127dex312.htm EX-31.2 6382
4 EX-32.1 d611127dex321.htm EX-32.1 4643
  Complete submission text file 0001193125-13-404110.txt   2426290

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxgn-20130630.xml EX-101.INS 314142
6 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20130630.xsd EX-101.SCH 23814
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20130630_cal.xml EX-101.CAL 28674
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20130630_def.xml EX-101.DEF 55711
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20130630_lab.xml EX-101.LAB 210271
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20130630_pre.xml EX-101.PRE 136008
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-21990 | Film No.: 131160164
SIC: 2836 Biological Products, (No Diagnostic Substances)